You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

18FDG

Showing 1 - 25 of 2,136
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rectal Cancer Trial (Chemoradiation treatment, 18FDG-PET/MRI scan)

Not yet recruiting
  • Rectal Cancer
  • Chemoradiation treatment
  • 18FDG-PET/MRI scan
  • (no location specified)
Sep 26, 2023

Idiopathic Pulmonary Fibrosis Trial in Paris (18FDG-PET scan)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • 18FDG-PET scan
  • Paris, France
    Service de Pneumologie A Centre constitutif de référence des mal
Oct 3, 2022

Non-Small Cell Bronchopulmonary Carcinoma or Melanoma Trial in Nice (18FDG PET)

Recruiting
  • Non-Small Cell Bronchopulmonary Carcinoma or Melanoma
  • 18FDG PET
  • Nice, France
    Centre Antoine Lacassagne
Sep 13, 2022

Cervical Cancer Squamous Cell Trial in Toronto (18-FDG PET/CT, DWI, DCE-MRI)

Completed
  • Cervical Cancer Squamous Cell
  • 18-FDG PET/CT, DWI, DCE-MRI
  • Toronto, Ontario, Canada
    University Health Network, The Princess Margaret
Nov 7, 2022

Type 2 Diabetes, Cardiovascular Risk Factor Trial in Catanzaro (Empagliflozin 10 MG, Glimepiride 2 mg)

Completed
  • Type 2 Diabetes
  • Cardiovascular Risk Factor
  • Empagliflozin 10 MG
  • Glimepiride 2 mg
  • Catanzaro, Italy
    Universital Hospital Mater Domini
Jan 14, 2023

Kidney Transplant Rejection, Kidney Transplant; Complications Trial in Liege (18FDG PET / CT)

Recruiting
  • Kidney Transplant Rejection
  • Kidney Transplant; Complications
  • 18FDG PET / CT
  • Liege, Liège, Belgium
    Antoine Bouquegneau
Feb 11, 2022

Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Duarte (procedure, other, device)

Recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • Malignant Solid Neoplasm
  • Computed Tomography
  • +3 more
  • Duarte, California
    City of Hope Medical Center
May 3, 2023

Giant Cell Arteritis Trial in Dijon (drug, other, biological, procedure)

Not yet recruiting
  • Giant Cell Arteritis
  • Tocilizumab treatment
  • +3 more
  • Dijon, France
    Chu Dijon Bourgogne
Sep 7, 2023

Contribution of PET/MRI in Locally Advanced Cervical Cancer

Not yet recruiting
  • Cervical Cancer
  • 18-FDG PET-MRI
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
Oct 12, 2023

Glioma Trial in Portland (Fludeoxyglucose F-18, Gadoterate Meglumine, Contrast-enhanced Magnetic Resonance Imaging)

Not yet recruiting
  • Glioma
  • Fludeoxyglucose F-18
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 30, 2023

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma Trial (drug,

Not yet recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +3 more
  • (no location specified)
Jan 24, 2023

Lung Carcinoma Trial in Philadelphia (Fludeoxyglucose F-18, Positron Emission Tomography, Computed Tomography)

Recruiting
  • Lung Carcinoma
  • Fludeoxyglucose F-18
  • +3 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Mar 7, 2023

Infections of the Implanted Material, Endocarditis Trial in France (Whole-body 18FDG-PET-CT scan)

Completed
  • Infections of the Implanted Material
  • Endocarditis
  • Whole-body 18FDG-PET-CT scan
  • Grenoble, France
  • +5 more
Feb 8, 2022

Hepatocellular Carcinoma Trial in Belgium (Liver transplantation)

Recruiting
  • Hepatocellular Carcinoma
  • Liver transplantation
  • Antwerpen, Belgium
  • +5 more
Aug 27, 2022

Prostate Cancer Trial in Québec (Pembrolizumab)

Recruiting
  • Prostate Cancer
  • Québec, Canada
    CHU de Québec-Université Laval
Mar 8, 2022

Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Malignant Tumor in the Spine Trial in Houston (Computed Tomography,

Recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Metastatic Malignant Neoplasm in the Spine
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 13, 2022

18F-FAPI, 18F-FDG, Pancreas Adenocarcinoma Trial in Hangzhou (18F-FAPI, 18F-FDG)

Completed
  • 18F-FAPI
  • +4 more
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
May 31, 2023

Hepatocellular Carcinoma Trial in Toronto (PET MRI)

Active, not recruiting
  • Hepatocellular Carcinoma
  • PET MRI
  • Toronto, Ontario, Canada
    Toronto General Hospital
Oct 31, 2022

Esophageal Cancer Trial in Taoyuan (PET/MRI)

Completed
  • Esophageal Cancer
  • PET/MRI
  • Taoyuan, Taiwan
    Linkou Chang Gung Memorial Hospital
May 9, 2023

Metastatic Malignant Tumor, Metastatic Malignant Tumor in the Bone Trial in Houston (Fludeoxyglucose F-18, Magnetic Resonance

Active, not recruiting
  • Metastatic Malignant Neoplasm
  • Metastatic Malignant Neoplasm in the Bone
  • Fludeoxyglucose F-18
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Esophageal Cancer Trial in Taoyuan (PET/MRI)

Completed
  • Esophageal Cancer
  • PET/MRI
  • Taoyuan, Taiwan
    Linkou Chang Gung Memorial Hospital
May 9, 2023

Neuroendocrine Tumors Trial in Toronto (F18-FDG)

Recruiting
  • Neuroendocrine Tumors
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 20, 2022

GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

Enrolling by invitation
  • GEP-NET
  • +3 more
  • Copenhagen, Denmark
    Rigshospitalet
Jan 24, 2023

Brain Glioblastoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18, Magnetic Resonance Imaging)

Completed
  • Brain Glioblastoma
  • Computed Tomography
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Breast Cancer Trial in Italy (Arm B, tumor markers assessment)

Active, not recruiting
  • Breast Cancer
  • Arm B, tumor markers assessment
  • Bressanone, Bolzano, Italy
  • +6 more
Dec 28, 2022